ALKERMES | ALKS - Pe Kurs-Gewinn





Pe Veränderung Datum
AbbVie 23.45 0.51 2026-09
Acadia Pharmaceuticals 9.52 1.81 2026-09
ALKERMES 262.4 126.59 2026-09
Amgen 18.6 0.53 2026-09
Biogen 29.15 5.92 2026-09
BioMarin Pharmaceutical 53.62 32.55 2026-09
Bristol-Myers Squibb 10.44 5.7 2026-09
Eli Lilly 64.5 31.61 2026-09
Gilead Sciences 17.68 4.18 2026-09
Ionis Pharmaceuticals 396.15 79.28 2022-09
J&J 25.86 3.57 2026-09
Malin Corporation 11.81 0.72 2023-06
Merck 34.36 2.11 2026-09
Neurocrine Biosciences 83.17 61.07 2026-09
Otsuka Holdings 15.2 2.2 2026-09
Ovoca Bio 1.83 3.29 2024-06
Pfizer 15.2 3.72 2026-09
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Vertex Pharmaceuticals 29.35 1.3 2026-09